Free public records show Advanced Marker Discovery S.l. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Advanced Marker Discovery S.l. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by Advanced Marker Discovery S.l., of 5 in all
Source: ClinicalTrials.gov, Studies with Advanced Marker Discovery S.l. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Advanced Marker Discovery S.l. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Advanced Marker Discovery S.l. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Advanced Marker Discovery S.l.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Advanced Marker Discovery S.l. is in.
Stories on the topics Advanced Marker Discovery S.l. works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Sequencing a human genome fell from about $50 million in 2003 to under $1,500 by late 2015. Bioinformatics…
ReadSearch all reports for Advanced Marker Discovery S.l. All companies